Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

TBK1/Ikkε Inhibitor Amlx Blocks Multiple Myeloma Cell Growth in Vitro and In Vivo

Quanhong Sun, PhD, Peng Zhang, PhDMD, Juraj Adamik, PhD, Konstantinos Lontos, MD, Valentina Marchica, MS, Nicola Giuliani, MD PhD, Rebecca W. Silbermann, MD, G. David Roodman, MD PhD, Deborah Lynn Galson, PhD

Blood (2018) 132 (Supplement 1): 4504.

https://doi.org/10.1182/blood-2018-99-119677

Published: 2018

Journal Articles

Coexistence of multiple myeloma and Paget disease of bone

Maryam Pourabdollah, Hong Chang

Blood (2017) 130 (9): 1173.

https://doi.org/10.1182/blood-2017-05-784199

Published: 2017

Journal Articles

Statin Use and Its Effects on Skeletal Related Events in Patients with Multiple Myeloma

Fernando M Vargas Madueno, MD, Amin Benyounes, MD, Gentry King, MD, Kuan-Hsiang Gary Huang, MDPhD, Gabor Varadi, MD

Blood (2014) 124 (21): 5774.

https://doi.org/10.1182/blood.V124.21.5774.5774

Published: 2014

Journal Articles

The Increased 1,25-(OH) 2 D 3 Sensitivity of Myeloma Cells and Marrow Stromal Cells Enhances RANKL Production and Tumor Cell Growth

Jumpei Teramachi, DDS, PhD, Noriyoshi Kurihara, DDS, PhD, John M Chirgwin, G David Roodman, MD, PhD

Blood (2012) 120 (21): 3946.

https://doi.org/10.1182/blood.V120.21.3946.3946

Published: 2012

Journal Articles

Neridronate (NE) for the Treatment of Osteoporosis In Patients with β-Thalassemia: Results from an Italian Multicenter Randomized, Open Label, Phase II Trial

Gian Luca Forni, MD, Silverio Perrotta, MD, Caterina Borgna Pignatti, MD, Domenico Giuseppe D'Ascola, MD, Bruno Nobili, MD, Lorella Pitrolo, MD, Giovanni Quarta, MD, Paolo Rigano, MD, Laura Zanaboni, MD, Ernesto Palummeri, MD

Blood (2010) 116 (21): 4282.

https://doi.org/10.1182/blood.V116.21.4282.4282

Published: 2010

Journal Articles

Evolution of Bisphosphonates RELATED Osteonecrosis of the Jaw (BRONJ) IN PATIENTS with MULTIPLE MYELOMA (MM) and WALDENSTROM'S Macroglobulinemia (WM): A Retrospective STUDY.

Alessandro Andriani, MD, Maria Teresa Petrucci, MD, Tommaso Caravita, M.D., Marco Montanaro, MD, Francesco Pisani, MD, Ugo Coppetelli, MD, Marianna De Muro, MD, Velia Bongarzoni, MD, Giuseppe Avvisati, MD, Nicoletta Villivà, MD, Anna Levi, MD, Agostina Siniscalchi, MD, Alessandro Agrillo, MD, Domenico Gaglioti, MD

Blood (2009) 114 (22): 2818.

https://doi.org/10.1182/blood.V114.22.2818.2818

Published: 2009

Journal Articles

The Effects of Zoledronic Acid on Serum Lipids in Multiple Myeloma Patients.

Alessandro Gozzetti, MD, PhD, Giuseppe Martini, MD, Annalisa Avanzati, BS, Beatrice Franci, MD, Elena Marchini, MD, Ranuccio Nuti, MD, Francesco Lauria, MD

Blood (2007) 110 (11): 4828.

https://doi.org/10.1182/blood.V110.11.4828.4828

Published: 2007

Journal Articles

Phase 1 Assessment of an Orally Bioavailable Formulation of Gallium Nitrate (G4544).

Thomas Julian, Shingai Majuru, Moses Oyewumi, Steven Novick, Miriam Mangelus, Bob Brown, Bharat Mehta, Raymond P. Warrell, Jr., Lewis H. Bender

Blood (2007) 110 (11): 4455.

https://doi.org/10.1182/blood.V110.11.4455.4455

Published: 2007

Journal Articles

Rac1 and Rac2 GTPases Play Distinct Roles and Are Essential for Full Osteoclast Differentiation.

Matti Korhonen, MD, Haibo Zhao, PhD, Roberta Faccio, PhD, Patric F. Ross, PhD, Tracy M. Hopkins, Jose A. Cancelas, MD, David A. Williams, MD

Blood (2006) 108 (11): 4231.

https://doi.org/10.1182/blood.V108.11.4231.4231

Published: 2006

Journal Articles

Osteonecrosis of the Jaw Associated with Chronic Bisphosphonates Therapy: An Italian Experience.

Anna M. Cafro, MD, Luciana A. Barbarano, MD, Alessandro Andriani, MD, Giovanna D’Avanzo, MD, Michele Nichelatti, PhD, Domenico Gaglioti, MD, Alberto Taroni, MD, Livio Gargantini, MD, Michela G. Draisci, MD, Enrica Morra, MD

Blood (2005) 106 (11): 5152.

https://doi.org/10.1182/blood.V106.11.5152.5152

Published: 2005

Journal Articles

Rac1 and Rac2 GTPases Play Distinct Roles and Are Essential for Full Osteoclast Differentiation.

Matti Korhonen, MD, Haibo Zhao, MD, PhD, Roberta Faccio, PhD, F. Patrick Ross, PhD, Tracy M. Hopkins, MS, Jose A. Cancelas, MD, Steven L. Teitelbaum, MD, David A. Williams, MD

Blood (2005) 106 (11): 67.

https://doi.org/10.1182/blood.V106.11.67.67

Published: 2005

Journal Articles

Nf1 Plays an Essential Role in Osteoclasts Development Via Hyperactivation of Ras- PI3K Signaling.

Shi Chen, David A. Ingram, M.D., Mary Jo Wenning, Janet Hock, M.D., Feng-Chun Yang, M.D., D. Wade Clapp, M.D.

Blood (2004) 104 (11): 1462.

https://doi.org/10.1182/blood.V104.11.1462.1462

Published: 2004

NARROW

TBK1/Ikkε Inhibitor Amlx Blocks Multiple Myeloma Cell Growth in Vitro and In Vivo

Coexistence of multiple myeloma and Paget disease of bone

Statin Use and Its Effects on Skeletal Related Events in Patients with Multiple Myeloma

The Increased 1,25-(OH) 2 D 3 Sensitivity of Myeloma Cells and Marrow Stromal Cells Enhances RANKL Production and Tumor Cell Growth

Neridronate (NE) for the Treatment of Osteoporosis In Patients with β-Thalassemia: Results from an Italian Multicenter Randomized, Open Label, Phase II Trial

Evolution of Bisphosphonates RELATED Osteonecrosis of the Jaw (BRONJ) IN PATIENTS with MULTIPLE MYELOMA (MM) and WALDENSTROM'S Macroglobulinemia (WM): A Retrospective STUDY.

The Effects of Zoledronic Acid on Serum Lipids in Multiple Myeloma Patients.

Phase 1 Assessment of an Orally Bioavailable Formulation of Gallium Nitrate (G4544).

Rac1 and Rac2 GTPases Play Distinct Roles and Are Essential for Full Osteoclast Differentiation.

Osteonecrosis of the Jaw Associated with Chronic Bisphosphonates Therapy: An Italian Experience.

Rac1 and Rac2 GTPases Play Distinct Roles and Are Essential for Full Osteoclast Differentiation.

Nf1 Plays an Essential Role in Osteoclasts Development Via Hyperactivation of Ras- PI3K Signaling.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only